Literature DB >> 11902486

Is peritoneal carcinomatosis an incurable disease or controllable locoregional condition?--Challenge of surgeons with intraperitoneal hyperthermic chemotherapy.

T Sano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11902486     DOI： 10.1093/jjco/hye141

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  6 in total

1.  Regional control of tumor growth.

Authors:  Alexander Zaslavsky; Catherine Chen; Jenny Grillo; Kwan-Hyuck Baek; Lars Holmgren; Sam S Yoon; Judah Folkman; Sandra Ryeom
Journal:  Mol Cancer Res       Date:  2010-08-24       Impact factor: 5.852

2.  High-quality results of cytoreductive surgery and heated intraperitoneal chemotherapy perfusion for carcinomatosis at a low volume institution.

Authors:  Swaroop R Bommareddi; Vlad V Simianu; Lisa V Mann; Gary N Mann
Journal:  J Surg Oncol       Date:  2015-08-14       Impact factor: 3.454

3.  Diagnosis of Peritoneal Carcinomatosis of Colorectal Origin Based on an Innovative Fuzzy Logic Approach.

Authors:  Valentin Bejan; Marius Pîslaru; Viorel Scripcariu
Journal:  Diagnostics (Basel)       Date:  2022-05-21

4.  The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe.

Authors:  Maciej Nowacki; Wojciech Zegarski
Journal:  J Int Med Res       Date:  2018-06-19       Impact factor: 1.671

Review 5.  Hemangiopericytoma: an unusual cause of peritoneal carcinomatosis.

Authors:  Mahesh Prakash; Hina Arif Mumtaz; Kushaljeet S Sodhi; R Kapoor; Niranjan Khandelwal
Journal:  Cancer Imaging       Date:  2009-06-15       Impact factor: 3.909

6.  Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons.

Authors:  Heon Jong Yoo; Jenny J Hong; Young Bok Ko; Mina Lee; Youjin Kim; Hye Young Han; Yong Jung Song; Myong Cheol Lim; Sang-Yoon Park
Journal:  World J Surg Oncol       Date:  2018-05-15       Impact factor: 2.754
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.